Archive | Bachem AG

Page 18 of 18
Bachem Add 9 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products
Bachem Add 9 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products Learn More >
Bachem Add 12 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products
Bachem Add 12 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products Learn More >
Chemical Synthesis of Interferon β-1a Successfully Developed
Chemical Synthesis of Interferon β-1a Successfully Developed Learn More >
Bachem Switches Financial Reporting from IFRS to Swiss GAAP FER
Bachem Switches Financial Reporting from IFRS to Swiss GAAP FER Learn More >
Bachem and Axon Neuroscience Sign Contract for Finished Dosage Forms of Peptide-Protein Conjugate
Bachem and Axon Neuroscience Sign Contract for Finished Dosage Forms of Peptide-Protein Conjugate Learn More >
Bachem Add 11 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products
Bachem Add 11 New Products to Online Catalogue of Peptides, Amino Acid Derivatives, Biochemical and Immunology Products Learn More >
Immunological Kits and Peptide Products Added to Online Catalogue
Immunological Kits and Peptide Products Added to Online Catalogue Learn More >
Peptide, Biochemicals and Immunology Products
Peptide, Biochemicals and Immunology Products Learn More >
Bachem Granted Manufacturing License by Japanese Ministry of Health Labour and Welfare
Bachem Granted Manufacturing License by Japanese Ministry of Health Labour and Welfare Learn More >
Bachem AG Release Seven New Products
Bachem AG Release Seven New Products Learn More >
Bachem Well Positioned in Demanding Market
Bachem Well Positioned in Demanding Market Learn More >
Fmoc-Tyrosine Derivative
Fmoc-Tyrosine Derivative Learn More >
Page 18 of 18